Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zeneca and UK Imperial Cancer Research Fund (ICRF) collaborate on cancer diagnostics

This article was originally published in Clinica

Executive Summary

Zeneca and the UK Imperial Cancer Research Fund (ICRF) have formed a partnership to develop DNA diagnostics for cancer. A joint committee will pick commercial prospects from targets identified by ICRF. Both organisations will be involved in early development. Clinical evaluation will be conducted by the ICRF and Zeneca will commercialise successful tests. The deal will provide ICRF with £1.2 million ($1.8 million) in research funding plus royalties on sales of diagnostic products.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094519

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel